Filing Details

Accession Number:
0001209191-23-018677
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-14 19:34:51
Reporting Period:
2023-03-12
Accepted Time:
2023-03-14 19:34:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1020214 Cerus Corp CERS Surgical & Medical Instruments & Apparatus (3841) 680262011
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1296322 J Richard Benjamin C/O Cerus Corporation
1220 Concord Ave Suite 600
Concord CA 94520
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-12 23,460 $0.00 356,125 No 4 M Direct
Common Stock Disposition 2023-03-13 9,606 $2.80 346,519 No 4 S Direct
Common Stock Acquisiton 2023-03-12 16,667 $0.00 363,186 No 4 M Direct
Common Stock Disposition 2023-03-13 5,747 $2.80 357,439 No 4 S Direct
Common Stock Disposition 2023-03-13 10,000 $2.78 347,439 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2023-03-12 23,460 $0.00 23,460 $0.00
Common Stock Restricted Stock Unit Disposition 2023-03-12 16,667 $0.00 16,667 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
16,666 No 4 M Direct
Footnotes
  1. Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.
  2. Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person.
  3. The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
  4. The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.75 to $2.895 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
  5. The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023.
  6. Not applicable.
  7. The restricted stock unit vests in three equal annual installments beginning on March 12, 2022.